# Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.

> **NCT06163573** · PHASE2 · RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 75 (estimated)

## Conditions studied

- Patellofemoral Osteoarthritis

## Interventions

- **BIOLOGICAL:** N-TEC
- **BIOLOGICAL:** Platelet rich plasma

## Key facts

- **NCT ID:** NCT06163573
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-06
- **Primary completion:** 2028-09
- **Final completion:** 2029-09
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06163573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06163573, "Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06163573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*